Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
COVID-19
Pneumococcal disease
2024
Americas
Clear all
Type of publications
NITAG documentation
(3)
Topics
Available to download in languages
Regions
Americas
(3)
Countries
Canada
(3)
Diseases
COVID-19
(1)
Pneumococcal disease
(2)
Mpox // Monkeypox
(1)
RSV (Respiratory syncytial virus)
(2)
Vaccine topics
Target population
Older adults
(1)
Publication date
2024
(3)
2023
(8)
2022
(15)
2021
(16)
2020
(4)
2015
(1)
2014
(1)
2010
(2)
2008
(1)
3 results found
2024
∙
NACI
Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines
2024
∙
NACI
Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines
2024
∙
NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register